Skip to main content
. 2021 Mar 24;14(4):288. doi: 10.3390/ph14040288

Figure 1.

Figure 1

Immune checkpoint pathways and their inhibitors in acute myeloid leukemia (AML) (inhibitors—marked with red arrows). PVR—poliovirus receptor, PVRL2—poliovirus receptor-related 2, HVEM—herpesvirus entry mediator.